Susumu Goyama
Minato, 1088639, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
NPM1-rearranged AML: clinical features, molecular pathogenesis, and therapeutic perspectives.
Journal: International journal of hematology
Published: February 13, 2026
Correction: Recent advances of cell therapies for AML/MDS: exploring the therapeutic potential of innate immune cells in AML/MDS.
Journal: International journal of hematology
Published: January 09, 2026
DAXX promotes SUMOylation of chromatin-trapped DNMT1.
Journal: Journal of biochemistry
Published: December 29, 2025
Advances in antisense oligonucleotide treatment for cancer.
Journal: Japanese journal of clinical oncology
Published: November 28, 2025
Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models.
Journal: Biochemical and biophysical research communications
Published: November 14, 2025
Development of hematopoietic stem cell-targeted lipid nanoparticles through lipid composition optimization.
Journal: Experimental hematology
Published: October 14, 2025
Recent advances of cell therapies for AML/MDS: exploring the therapeutic potential of innate immune cells in AML/MDS.
Journal: International journal of hematology
Published: October 04, 2025
Myeloid tumors and antitumor innate immunity
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 01, 2025
Bortezomib Restores Venetoclax Sensitivity in Acute Myeloid Leukemia Cell Lines with Intrinsic and Acquired Resistance.
Journal: Molecular cancer therapeutics
Published: August 18, 2025
Last Updated: 09/26/2026